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Abstract
Surgical revascularization remains the standard of care for many patients. Off-pump coronary artery bypass grafting (OPCAB) without car-
diopulmonary bypass (CPB) has evolved during the past 20 years, and as such can significantly reduce the occurrence of neurological com-
plications. While avoiding the aortic cross-clamping required in conventional on-pump techniques, OPCAB results in a lower incidence of
stroke. However, clamp-related risk of stroke remains if partial or side-biting clamps are applied for proximal anastomoses. Others and we
have demonstrated that no-touch ‘anaortic’ approaches avoiding any clamping during off-pump procedures via complete in situ grafting
result in significantly reduced stroke rates when compared with partial clamping. Therefore, OPCAB in situ grafting has been proposed as
the ‘standard of care’ to reduce neurological complications. However, this technique may not be applicable to for every patient as the use
of free grafts (arterial or venous) requiring proximal anastomosis is often still necessary to achieve complete revascularization. In these
situations, proximal anastomosis can be performed without a partial clamp by using the HEARTSTRING device, and over the last few years,
considerable evidence has arisen supporting the impact of HEARTSTRING-enabled anastomosis to significantly minimize atheroembolism
and neurological complications when compared with partial- or side-bite clamping. This paper provides a systematic overview and tech-
nical information about the combination of OPCAB and clampless strategies using the HEARTSTRING for proximal anastomosis to reduce
stroke to levels reported for percutaneous coronary intervention.
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INTRODUCTION
Surgical revascularization remains the gold standard treatment for
patients with complex three-vessel coronary artery disease, left
main coronary artery involvement or diabetes mellitus [1, 2].
Landmark trials published during the last years provide strong
confirmation for the superiority of coronary artery bypass grafting
(CABG) over percutaneous coronary intervention (PCI) for long-
term survival, cardiac events and repeat revascularization [3–5].
However, the significantly higher occurrence of stroke reported
for CABG patients compared with PCI is a major concern and
often used as an argument against conventional CABG [6].
In the 5-year follow-up of the SYNTAX trial [4], CABG patients
fared better than PCI in regard to cardiac death, myocardial in-
farction (MI), repeat revascularization, the composites of all-cause
death/cerebrovascular accident/MI and MACCE. Based on these
findings, investigators again concluded that CABG remains the
gold standard treatment for patients with moderate and highly
complex multivessel disease (elevated Syntax score); PCI was
reserved as an alternative for the minority of patients with the
least complex disease (low Syntax score). In addition, the recent
FREEDOM trial results demonstrated 5-year superiority for CABG
in diabetic patients across all degrees of lesion complexity [3].
Diabetic patients who underwent CABG had significantly better
outcomes than those who underwent PCI on death, MI and the
composite of death/MI/stroke. Recommendations that consent be
obtained in a heart team setting from all diabetic CAD patients,
followed the publication of these results [6]. In regard to long-term
outcomes, the ASCERT trial tracked 86 244 CABG patients and
103 549 PCI patients over age 65 with two- or three-vessel disease
not requiring emergency treatment by linking the Society of
Thoracic Surgery (STS) Adult Cardiac Surgery and American
College of Cardiology Foundation databases [5]. Consistent with the
SYNTAX and FREEDOM trials, 4-year mortality was significantly
lower for CABG than PCI. Furthermore, this long-term survival
advantage persisted among patients whose propensity scores were
most consistent with the selection for PCI.
Despite the significant advantages in long-term event-free sur-
vival highlighted by these reports, higher stroke rates at one year
were cited as a significant limitation for CABG in both SYNTAX
(2.2 vs 0.6%; P = 0.003) and FREEDOM (5.2 vs 2.4%, P = 0.03) trials.
While stroke rates did not significantly differ at 5 years, the higher
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1-year rates perpetuate concern about the risk of stroke associated
with surgery.
Recent meta-analyses have also reported elevated stroke rates
for CABG vs PCI. The most recent and largest meta-analysis to
date [7], consisting of 19 randomized trials across 10 994 patients,
concluded that 30-day stroke was almost three times more
common with CABG than PCI [1.20 vs 0.34%; odds ratio (OR) 2.94;
95% confidence interval (CI), 1.69–5.09; P < 0.0001]. An accom-
panying examination of outcomes in 33 980 patients from 27 ob-
servational studies led researchers to conclude that the higher
CABG stroke rate observed in randomized studies was representa-
tive of real-world outcomes.
THE OVERALL VALUE OF OFF-PUMP CORONARY
ARTERY BYPASS
In parallel to conventional CABG techniques, off-pump coronary
artery bypass grafting (OPCAB) without cardiopulmonary bypass
(CPB) has evolved during the past 20 years and is slowly gaining
acceptance and popularity in numerous centres worldwide.
However, the truth being, except selected specialist centres per-
forming >90% cases in an OPCAB fashion, the adoption of OPCAB
has been very limited around the globe and accounts for only
20% of the current practice in the USA and Europe [8, 9].
Meta-analyses of randomized controlled trials in low-risk patients
display comparable results for both approaches with regard to mor-
tality, MI, and need for repeat revascularization at 1 and 2 years.
They also demonstrate OPCAB to be associated with reduction of
stroke, wound infection, renal and respiratory complications [9–11].
Next, OPCAB appears to reduce the need for transfusion, inotropic
support, ventilation time, the length of hospital stay, and in-hospital
and 1-year direct costs [8]. These data were confirmed recently in a
large meta-analysis including 35 propensity score analyses with a
total of 123 137 patients. This study detected an overall OR <1 for all
outcome parameters in favour of OPCAB. These results were signifi-
cant for most of the evaluated outcome parameters, in particular
mortality, suggesting OPCAB to be the superior technique when
compared with CABG [12].
In contrast, the ROOBY trial showed a 30% risk increase for the
occurrence of the primary composite endpoint including death, MI
and need for repeat revascularization after OPCAB [13]. However,
this prospective randomized multicentre trial displayed several
major limitations, as >70% of the evaluated patients were excluded
due to clinical reservations of surgeons who accepted participation
in the study after they had performed only 20 OPCAB procedures.
This lack of experience was also highlighted by the up to 10-fold
higher need for conversion to on-pump (12%), when compared
with specialized OPCAB centres that report conversion rates
ranging from 1 to 5% [14]. More than 50% of OPCAB patients
received transfusions vs only 30% reported in previous randomized
trials, and only a small proportion of the cohort were high-risk
patients, the suggested subgroup to benefit more likely from
OPCAB. And finally only a good team approach with experienced
anesthesiologists will yield good results for OPCAB.
WHOARE THE TARGET PATIENTS FOR OFF-
PUMP CORONARY ARTERY BYPASS?
Observational studies suggest that OPCAB is particularly beneficial
for high-risk patients, including those with left ventricle dysfunction,
high calcific load, age older than 75 years, diabetes, renal failure,
left main stem disease, reoperations, chronic pulmonary disease
and an overall EuroSCORE >5 [10–12, 15–19]. In contrast, in the pro-
spective Best Bypass Surgery trial, Moller et al. [20] compared out-
comes in 341 patients that were randomly assigned to either
on-pump or off-pump surgery. At 3 years, this trial did not detect
any significant differences with regards to MACCE. However, to
date, there is only one multicentre, prospective randomized trial
available comparing OPCAB vs on-pump in high-risk patients,
whereas at least two trials are underway to evaluate the potential
benefit of OPCAB in this subset of patients. The CRISP trial con-
ducted by both the Oxford and Bristol Cardiac Surgery Unit is an
international randomized multicentre trial aiming for >5000 high-
risk patients with an inclusion criterion of a EuroSCORE >5.
Recently, the German Off-Pump Coronary Artery Bypass in Elderly
Study (GOPCABE), a multicentre trial randomly assigning 2539
patients older than 75 years to undergo either OPCAB or on-pump,
concluded that no significant difference in regard to neurological
outcomes was seen The stroke rate of 2.2% in the OPCAB is,
however, very high, but no information on aortic techniques was
provided to the reader [21].
STROKE REDUCTIONWITH OFF-PUMP
CORONARY ARTERY BYPASS
Reports of inferior neurological outcomes for CABG vs PCI have
primarily resulted from studies in which conventional on-pump
CABG (ONCAB) techniques were used, rather than OPCAB, aortic
no-touch strategies or the combination of both. In the SYNTAX
trial, only 15% of the patients underwent OPCAB and in the
FREEDOM trial, use of cardiopulmonary bypass was left to the sur-
geon’s discretion, with the result that only 20% patients underwent
off-pump surgery [3].
There is a compelling body of evidence that OPCAB significantly
reduces cerebrovascular complications [22–24]. A propensity-
matched analysis of 30-day outcomes in >42 477 consecutive
primary isolated CABG patients in the STS Adult Cardiac Surgery
database documented a 35% reduction in stroke for OPCAB com-
pared to conventional CABG (OR 0.65, P = 0.001) [25]. A 2012
meta-analysis of 59 randomized controlled trials encompassing
8961 patients [26] documented a 30% reduction in the risk of post-
operative stroke with OPCAB vs ONCAB [1.4 vs 2.1%; relative risk
(RR) 0.70, 95% CI 0.49–0.99]. An analagous meta-analysis of 35
propensity-adjusted observational studies across a total of
123 137 patients [12] detected a significant reduction in stroke
with OPCAB (OR 0.42; 95% CI 0.33–0.54; P < 0.0001).
ADDITIONAL STROKE REDUCTIONWITH
CLAMPLESS OFF-PUMP CORONARY
ARTERY BYPASS
By eliminating aortic manipulation and cross-clamping required
for cardiopulmonary bypass, OPCAB results in a lower incidence
of stroke compared with conventional CABG. However, significant
clamp-related risk of stroke remains if partial or side-biting clamps
are used during the construction of proximal anastomoses.
‘Anaortic’ approaches avoiding any clamping during off-pump
procedures via complete in situ grafting (double internal
mammary artery and/or T- or Y-grafting) have resulted in stroke
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rates that are significantly lower than both conventional CABG
and OPCAB with partial clamping.
A 2011 meta-analysis of seven observational studies compared
clampless OPCAB with conventional CABG and OPCAB with the
use of partial clamp [22]. Avoidance of clamping during OPCAB
was associated with a significant reduction in risk of stroke com-
pared with conventional CABG (0.38 vs 1.87% RR 0.27; 95% CI
0.14–0.58; P < 0.0001) as well as compared with OPCAB using a
partial clamp (0.31 vs 1.35%; RR 0.34; CI 95% 0.18–0.65; P = 0.001).
A similar meta-analysis of eight studies and 11 398 patients com-
pared neurological complications in off-pump surgery conducted
with and without aortic manipulation [27]. Postsurgical neuro-
logical complications were reduced by half in anaortic OPCAB
grafting cases (OR 0.46; 95% CI, 0.29–0.72; P = 0008).
Halbersma et al. [28] recently compared 4-year outcomes in 400
consecutive no-touch total arterial OPCAB patients with results in
the surgical arm of the SYNTAX trial. There was a clear trend towards
a reduction in the event rate of stroke in the no-touch group (0.8%)
compared with the surgical arm of the SYNTAX trial (2.2%). Further,
there was no significant difference of stroke rate between the
no-touch OPCAB group and the PCI arm of the SYNTAX trials.
Based on these results, Halbersema et al. [28] and others [22, 24]
have proposed off-pump in situ grafting as the ‘standard of care’ to
reduce neurological complications. However, this approach may not
be applicable for every patient or in every surgical setting. In many
cases to obtain complete revascularization, the use of free grafts
(arterial or venous) requiring proximal anastomosis is necessary. In
these situations, proximal anastomosis can be performed without a
partial clamp by using the HEARTSTRING Proximal Seal System
(MAQUET, San Jose, CA, USA).
HEARTSTRING-ENABLED CLAMPLESS PROXIMAL
ANASTOMOSIS
The HEARTSTRING Proximal Seal System consists of a specialized
aortic cutter, a delivery device and the proximal seal. First, we rec-
ommend that the delivery device be bathed for a couple of
seconds in warm saline to ensure smooth deployment. We do not
use epi-aortic scanning, the aorta can be prepared for a side bite
clamping (preventative measure), then identification of anasto-
motic site is done and the adventitia is prepared. The insertion of
a swab between the aorta and the right pericardial reflection will
help with the exposure for the anastomosis. The graft is prepared
for suturing to the aorta, and a mean arterial blood pressure of
<70 mmHg is achieved. Then, a circular aortomy is made by using
the aortic cutter. Once the hole is made, it is covered with the
fingertip to prevent uncontrolled spurting of blood. In the next
step, the proximal seal is delivered into the aorta through the
hole. To make this manoeuvre easier, we recommend slight rota-
tional movements of the device until a true penetration of the
ventral wall is felt. While retracting the sheeth with one hand,
the other is used to stabilize the HEARTSTRING device during this
maneuver. After the seal system is unfolded within the aorta,
the proximal anastomosis can be performed within the sealed
area (Fig. 1). A fine tip sucker is mandatory to keep the operation
field bloodless. When the anastomosis is finished, the seal system
is removed with a specially designed removal mechanism.
Over the last few years, considerable evidence has accrued
supporting the impact of HEARTSTRING in significantly minimiz-
ing atheroembolism and neurological complications compared
with partial- or side bite clamping. Guerrieri Wolf et al. [29]
documented a significant reduction in the proportion of particu-
late emboli with HEARTSTRING vs partial clamp using transcra-
nial Doppler monitoring of the middle cerebral artery in a
prospective study of patients with undocumented degrees of
aortic disease. A randomized study from Emory University
showed a significant reduction in particulate emboli with
HEARTSTRING in patients at low risk for atheroembolism; in
patients with no or minimal (Class I and II) aortic disease,
HEARTSTRING was associated with a 35% reduction in solid
emboli compared with the partial clamp [30].
Additional evidence that use of HEARTSTING to avoid aortic
side-clamping during OPCAB reduces stroke comes from several
reported series. Hilker et al. [30] performed 542 proximal anasto-
moses off-pump using the HEARTSTRING device in 412 consecu-
tive patients. Previous neurological disorders or cerebrovascular
diseases were documented in 15% of patients. The overall inci-
dence of postoperative stroke was 0.48% in contrast to a 1.3% pre-
dicted stroke risk score.
Douglas and Spaniol [31] reported a stroke rate of 0.8% for
patients who underwent CABG off-pump with the replacement of
partial clamping by HEARTSTRING in patients with severe aortic
disease identified using epiaortic ultrasound. The authors stressed
the role of clampless OPCAB as an important tool for the preven-
tion of postoperative stroke and also concluded that adjunctive
Figure 1: HEARTSTRING-enabled technique for proximal anastomosis. Digital palpation is performed to identify a soft (non-calcified) segment of aorta. Thereafter,
the adventitial tissue is mobilized, and cauterized to expose the media. Then a circular aortotomy is created using the aortic-punch device before the coiled
HEARTSTRING is inserted. The anastomosis is then performed with a continuous 6–0 Prolene RB suture, a blower/mister or fine tip cell saver is necessary to provide a
bloodless field and allow for precise transmural bites. After completion of the anastomosis and before tightening of the suture, the device is removed.
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techniques for patients with significant atherosclerosis is likely to
have been a major factor in reducing the occurrence of stroke.
Finally, a recent propensity-matched analysis of 4314 patients
comparing aortic cross-clamping during conventional on-pump
surgery vs partial clamping in OPCAB vs a clampless strategy using
the HEARTSTRING device showed that the occurrence of
stroke and MACCE can be significantly reduced by using the
HEARTSTRING device, yielding results similar to those that can be
achieved with no-touch total arterial in situ grafting [18].
Importantly, there was no difference in the rate of stroke between
patients who underwent a conventional on-pump approach with
aortic cross-clamping and patients who received off-pump
surgery in combination with partial clamping for proximal anasto-
mosis, suggesting that it is not the type of clamping, but clamping
itself, which is an independent predictor for an increased risk of
stroke [19].
CONCLUSION
Neurological outcomes are critical in the ongoing debate between
interventional and surgical treatment of CAD. The combination of
OPCAB and clampless strategies either using complete in situ graft-
ing techniques or clampless devices such as HEARTSTRING for
proximal anastomosis reduces stroke to levels comparable with PCI.
OPCAB in combination with no-touch or HEARTSTRING-enabled
proximal anastomotic techniques represent a significant advance
over conventional on-pump CABG by achieving the benefits of sur-
gical revascularization with less morbidity and comparable neuro-
logical complications as reported for PCI.
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